ABEV vs TGT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ABEV's deterministic health score is weak with a Piotroski F-Score of 4/9, indicating marginal financial stability. The stock trades above the Graham Number of $2.24 at a current price of $2.78, suggesting modest overvaluation for a defensive stock, though below the growth-based intrinsic value of $5.9. Strong profitability metrics like a 17.73% profit margin and 26.01% operating margin are offset by declining revenue growth of -5.70% YoY and a concerning 104.3% dividend payout ratio. Analysts rate it a 'hold' with a $2.93 target, implying limited upside.
TGT shows neutral fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
ABEV vs TGT: Head-to-Head Comparison
This page compares Ambev S.A. (ABEV) and Target Corporation (TGT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.